The Pain Relief Medication Market is expected to register a CAGR of 5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Pain Relief Medication Market report covers segmental analysis by Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Opioids, Others); Indication (Cancer Pain, Neuropathic Pain, Musculoskeletal Pain, Others); Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Pain Relief Medication Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Pain Relief Medication Market Segmentation
Drug Class- Nonsteroidal Anti-Inflammatory Drugs
- Opioids
- Cancer Pain
- Neuropathic Pain
- Musculoskeletal Pain
- Hospital and Retail Pharmacies
- Online Pharmacies
Strategic Insights
Pain Relief Medication Market Growth Drivers- Rising Awareness of Pain Management Options: Public awareness about chronic pain management has increased, especially through digital health platforms, educational campaigns, and healthcare provider consultations. This shift in consumer consciousness about available pain relief medications has led to greater demand for both non-prescription and prescription painkillers. With an increased understanding of how to manage pain effectively, people are more proactive in seeking solutions.
- Growth in the Elderly Population: The global rise in life expectancy has led to a larger elderly population who often face chronic pain due to age-related conditions such as osteoarthritis, osteoporosis, and other musculoskeletal disorders. As the elderly demographic continues to expand, the demand for effective pain relief medications will also increase, contributing significantly to market growth.
- Shift Toward Non-Opioid Alternatives: In response to the opioid crisis and growing concerns over opioid addiction, there has been a marked shift towards non-opioid pain relief medications. This shift includes the growing popularity of non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, topical analgesics, and other non-addictive pain relief options. Consumers and healthcare providers are increasingly seeking safer, non-habit-forming alternatives, thus driving the demand for new pain relief medications.
- Rise of Cannabis-Based Pain Relief Medications: Cannabis and its derivatives, especially cannabidiol (CBD) and tetrahydrocannabinol (THC), are gaining recognition in the pain relief landscape. With the growing legalization and acceptance of cannabis for medicinal use, the Pain Relief Medication Market will likely experience an increase in the development and availability of cannabis-based pain relief products. These products are seen as alternatives to traditional opioids, providing effective pain relief with lower risks of dependency. The market for CBD oils, tinctures, and topicals will continue to expand, appealing to a broader audience seeking natural and non-addictive pain management options.
- Growth of Over-the-Counter (OTC) Pain Relief Options: The demand for over-the-counter (OTC) pain relief medications is set to increase as consumers seek more accessible, cost-effective treatments for managing pain. As the OTC market for pain relief expands, companies will likely innovate in providing easier-to-use, fast-acting, and long-lasting OTC options. These products will cater to a wide range of conditions, from mild headaches and muscle pain to more chronic pain, making them an essential part of the evolving pain relief landscape. Additionally, the rise of telemedicine will allow consumers to receive expert recommendations on OTC pain relief medications, further driving their use.
- Enhanced Use of Digital Health Platforms for Pain Management: Digital health platforms and mobile health apps are expected to play a more prominent role in the future of the Pain Relief Medication Market. These platforms offer patients the ability to track their pain levels, monitor medication effectiveness, and communicate directly with healthcare providers. In addition, virtual consultations and prescriptions will become increasingly common, enabling patients to receive pain relief medications conveniently from the comfort of their homes. The integration of digital tools into pain management will streamline the process, making it easier for patients to manage their conditions effectively.
- Advancement of Digital Health and Telemedicine Integration: Digital health technologies, including telemedicine, remote monitoring, and pain management apps, present a significant opportunity to enhance the Pain Relief Medication Market. With more patients turning to digital platforms for consultations, prescriptions, and management of chronic pain, companies that integrate their pain relief solutions with digital tools can offer enhanced customer engagement. Mobile apps and wearable devices that track pain levels, medication usage, and overall health can help personalize treatment plans, creating a seamless and more effective pain management experience. This integration can also provide valuable data for pharmaceutical companies to refine their products and improve patient outcomes.
- Rise of Plant-Based and Natural Pain Relief Products: Consumers are becoming increasingly interested in plant-based and natural health products, including in the Pain Relief Medication Market. Cannabis-derived products, such as CBD oils and creams, are growing in popularity as alternatives to traditional pain medications. Additionally, plant-based options like turmeric, ginger, and menthol are gaining recognition for their pain-relieving properties. As demand for natural, organic, and sustainable products increases, companies have a significant opportunity to expand their portfolios to include plant-based or herbal pain relief solutions. This trend not only aligns with consumer preferences but also taps into the broader wellness movement.
- Targeting Niche Pain Conditions: The Pain Relief Medication Market offers substantial opportunities for companies to target niche pain conditions that may not be adequately addressed by current therapies. These include rare types of pain, such as neuropathic pain, fibromyalgia, and complex regional pain syndrome (CRPS). By developing specialized medications and treatment regimens for these conditions, companies can cater to an underserved market, improve patient outcomes, and differentiate themselves in a competitive marketplace. Investing in research and development to address these niche areas can provide a unique selling point for pharmaceutical companies.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Pain Relief Medication Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Pain Relief Medication Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Pain Relief Medication Market is expected to register a CAGR of 5% from 2025-2031.
The major factors impacting the Pain Relief Medication Market are: Rising Awareness of Pain Management Options, Growth in the Elderly Population and Shift Toward Non-Opioid Alternatives
Key future trends in this market are - Rise of Cannabis-Based Pain Relief Medications, Growth of Over-the-Counter (OTC) Pain Relief Options, Enhanced Use of Digital Health Platforms for Pain Management
Key companies of this market are: AbbVie Inc. (US), Allergan PLC (Ireland), Astellas Pharma Inc. (Japan), Bayer (Germany), Biogen Idec (US), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb (US), Eli Lilly and Company (US), GlaxoSmithKline (UK), Mallinckrodt Pharmaceuticals (UK), Pfizer, Inc. (US), Purdue Pharma (US), Sanofi (France)
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pain Relief Medication Market - By Drug Class
1.3.2 Pain Relief Medication Market - By Indication
1.3.3 Pain Relief Medication Market - By Distribution Channel
1.3.4 Pain Relief Medication Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PAIN RELIEF MEDICATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PAIN RELIEF MEDICATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PAIN RELIEF MEDICATION MARKET - GLOBAL MARKET ANALYSIS
6.1. PAIN RELIEF MEDICATION - GLOBAL MARKET OVERVIEW
6.2. PAIN RELIEF MEDICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.1. Overview
7.3.2. Nonsteroidal Anti-Inflammatory Drugs Market Forecast and Analysis
7.4. OPIOIDS
7.4.1. Overview
7.4.2. Opioids Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER PAIN
8.3.1. Overview
8.3.2. Cancer Pain Market Forecast and Analysis
8.4. NEUROPATHIC PAIN
8.4.1. Overview
8.4.2. Neuropathic Pain Market Forecast and Analysis
8.5. MUSCULOSKELETAL PAIN
8.5.1. Overview
8.5.2. Musculoskeletal Pain Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PAIN RELIEF MEDICATION MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
10. PAIN RELIEF MEDICATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pain Relief Medication Market Overview
10.1.2 North America Pain Relief Medication Market Forecasts and Analysis
10.1.3 North America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.1.4 North America Pain Relief Medication Market Forecasts and Analysis - By Indication
10.1.5 North America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pain Relief Medication Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pain Relief Medication Market
10.1.6.1.1 United States Pain Relief Medication Market by Drug Class
10.1.6.1.2 United States Pain Relief Medication Market by Indication
10.1.6.1.3 United States Pain Relief Medication Market by Distribution Channel
10.1.6.2 Canada Pain Relief Medication Market
10.1.6.2.1 Canada Pain Relief Medication Market by Drug Class
10.1.6.2.2 Canada Pain Relief Medication Market by Indication
10.1.6.2.3 Canada Pain Relief Medication Market by Distribution Channel
10.1.6.3 Mexico Pain Relief Medication Market
10.1.6.3.1 Mexico Pain Relief Medication Market by Drug Class
10.1.6.3.2 Mexico Pain Relief Medication Market by Indication
10.1.6.3.3 Mexico Pain Relief Medication Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pain Relief Medication Market Overview
10.2.2 Europe Pain Relief Medication Market Forecasts and Analysis
10.2.3 Europe Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Pain Relief Medication Market Forecasts and Analysis - By Indication
10.2.5 Europe Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pain Relief Medication Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pain Relief Medication Market
10.2.6.1.1 Germany Pain Relief Medication Market by Drug Class
10.2.6.1.2 Germany Pain Relief Medication Market by Indication
10.2.6.1.3 Germany Pain Relief Medication Market by Distribution Channel
10.2.6.2 France Pain Relief Medication Market
10.2.6.2.1 France Pain Relief Medication Market by Drug Class
10.2.6.2.2 France Pain Relief Medication Market by Indication
10.2.6.2.3 France Pain Relief Medication Market by Distribution Channel
10.2.6.3 Italy Pain Relief Medication Market
10.2.6.3.1 Italy Pain Relief Medication Market by Drug Class
10.2.6.3.2 Italy Pain Relief Medication Market by Indication
10.2.6.3.3 Italy Pain Relief Medication Market by Distribution Channel
10.2.6.4 Spain Pain Relief Medication Market
10.2.6.4.1 Spain Pain Relief Medication Market by Drug Class
10.2.6.4.2 Spain Pain Relief Medication Market by Indication
10.2.6.4.3 Spain Pain Relief Medication Market by Distribution Channel
10.2.6.5 United Kingdom Pain Relief Medication Market
10.2.6.5.1 United Kingdom Pain Relief Medication Market by Drug Class
10.2.6.5.2 United Kingdom Pain Relief Medication Market by Indication
10.2.6.5.3 United Kingdom Pain Relief Medication Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pain Relief Medication Market Overview
10.3.2 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis
10.3.3 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pain Relief Medication Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pain Relief Medication Market
10.3.6.1.1 Australia Pain Relief Medication Market by Drug Class
10.3.6.1.2 Australia Pain Relief Medication Market by Indication
10.3.6.1.3 Australia Pain Relief Medication Market by Distribution Channel
10.3.6.2 China Pain Relief Medication Market
10.3.6.2.1 China Pain Relief Medication Market by Drug Class
10.3.6.2.2 China Pain Relief Medication Market by Indication
10.3.6.2.3 China Pain Relief Medication Market by Distribution Channel
10.3.6.3 India Pain Relief Medication Market
10.3.6.3.1 India Pain Relief Medication Market by Drug Class
10.3.6.3.2 India Pain Relief Medication Market by Indication
10.3.6.3.3 India Pain Relief Medication Market by Distribution Channel
10.3.6.4 Japan Pain Relief Medication Market
10.3.6.4.1 Japan Pain Relief Medication Market by Drug Class
10.3.6.4.2 Japan Pain Relief Medication Market by Indication
10.3.6.4.3 Japan Pain Relief Medication Market by Distribution Channel
10.3.6.5 South Korea Pain Relief Medication Market
10.3.6.5.1 South Korea Pain Relief Medication Market by Drug Class
10.3.6.5.2 South Korea Pain Relief Medication Market by Indication
10.3.6.5.3 South Korea Pain Relief Medication Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pain Relief Medication Market Overview
10.4.2 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis
10.4.3 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pain Relief Medication Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pain Relief Medication Market
10.4.6.1.1 South Africa Pain Relief Medication Market by Drug Class
10.4.6.1.2 South Africa Pain Relief Medication Market by Indication
10.4.6.1.3 South Africa Pain Relief Medication Market by Distribution Channel
10.4.6.2 Saudi Arabia Pain Relief Medication Market
10.4.6.2.1 Saudi Arabia Pain Relief Medication Market by Drug Class
10.4.6.2.2 Saudi Arabia Pain Relief Medication Market by Indication
10.4.6.2.3 Saudi Arabia Pain Relief Medication Market by Distribution Channel
10.4.6.3 U.A.E Pain Relief Medication Market
10.4.6.3.1 U.A.E Pain Relief Medication Market by Drug Class
10.4.6.3.2 U.A.E Pain Relief Medication Market by Indication
10.4.6.3.3 U.A.E Pain Relief Medication Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pain Relief Medication Market Overview
10.5.2 South and Central America Pain Relief Medication Market Forecasts and Analysis
10.5.3 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pain Relief Medication Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pain Relief Medication Market
10.5.6.1.1 Brazil Pain Relief Medication Market by Drug Class
10.5.6.1.2 Brazil Pain Relief Medication Market by Indication
10.5.6.1.3 Brazil Pain Relief Medication Market by Distribution Channel
10.5.6.2 Argentina Pain Relief Medication Market
10.5.6.2.1 Argentina Pain Relief Medication Market by Drug Class
10.5.6.2.2 Argentina Pain Relief Medication Market by Indication
10.5.6.2.3 Argentina Pain Relief Medication Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PAIN RELIEF MEDICATION MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PAIN RELIEF MEDICATION MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC. (US)
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN PLC (IRELAND)
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ASTELLAS PHARMA INC. (JAPAN)
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAYER (GERMANY)
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOGEN IDEC (US)
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BOEHRINGER INGELHEIM INTERNATIONAL GMBH (GERMANY)
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BRISTOL-MYERS SQUIBB (US)
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ELI LILLY AND COMPANY (US)
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLAXOSMITHKLINE (UK)
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MALLINCKRODT PHARMACEUTICALS (UK)
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
13.11. PFIZER, INC. (US)
13.11.1. Key Facts
13.11.2. Business Description
13.11.3. Products and Services
13.11.4. Financial Overview
13.11.5. SWOT Analysis
13.11.6. Key Developments
13.12. PURDUE PHARMA (US)
13.12.1. Key Facts
13.12.2. Business Description
13.12.3. Products and Services
13.12.4. Financial Overview
13.12.5. SWOT Analysis
13.12.6. Key Developments
13.13. SANOFI (FRANCE)
13.13.1. Key Facts
13.13.2. Business Description
13.13.3. Products and Services
13.13.4. Financial Overview
13.13.5. SWOT Analysis
13.13.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. AbbVie Inc. (US)
2. Allergan PLC (Ireland)
3. Astellas Pharma Inc. (Japan)
4. Bayer (Germany)
5. Biogen Idec (US)
6. Boehringer Ingelheim International GmbH (Germany)
7. Bristol-Myers Squibb (US)
8. Eli Lilly and Company (US)
9. GlaxoSmithKline (UK)
10. Mallinckrodt Pharmaceuticals (UK)
11. Pfizer, Inc. (US)
12. Purdue Pharma (US)
13. Sanofi (France)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For